Overcoming Drug Resistance in NRAS-Mutant Melanoma...
Hee Won Yang‘s Abstract Melanoma is an aggressive type of skin cancer known for its rapid spread and frequent resistance to current treatments. Many advanced melanoma...
Hee Won Yang‘s Abstract Melanoma is an aggressive type of skin cancer known for its rapid spread and frequent resistance to current treatments. Many advanced melanoma...
Lilit Karapetyan’s Abstract Tumor infiltrating lymphocyte (TIL) therapy represents a promising approach for the treatment of patients whose disease does not benefit f...
Alexander Huang’s Abstract Radiation can be used as a vaccine, to increase the effect of immunotherapy. We call this Radvax, which is promising. Even in melanoma pati...
BC Pilot – James W. Smithy, MD, MHS
Description: Although immune checkpoint inhibitors (ICI) such as programmed death-1 (PD-1) blockade have made meaningful advances in the treatment of melanoma, drug resista...
Pilot Proposal – Keiran Smalley, PhD
Apr 06, 2026 ET
Apr 17, 2026 ET - Apr 19, 2026
Apr 19, 2026 PT